Safety and activity of an engineered, liver-tropic adeno-associated virus vector expressing a hyperactive Padua factor IX administered with prophylactic glucocorticoids in patients with haemophilia B: a single-centre, single-arm, phase 1, pilot trial

医学 因子IX 不利影响 血友病 内科学 血友病B 血液学 入射(几何) 胃肠病学 外科 血友病A 光学 物理
作者
Feng Xue,Huiyuan Li,Xia Wu,Wei Liu,Feixu Zhang,Dingyue Tang,Yunfei Chen,Wentian Wang,Ying Chi,Zheng Jing,Zengmin Du,Wei Jiang,Chen Zhong,Jun Wei,Ping Zhu,Rongfeng Fu,Xiao Fan Liu,Ling‐Ling Chen,Xiaolei Pei,Junjiang Sun
出处
期刊:The Lancet Haematology [Elsevier BV]
卷期号:9 (7): e504-e513 被引量:44
标识
DOI:10.1016/s2352-3026(22)00113-2
摘要

A novel, engineered, liver-tropic adeno-associated virus vector expressing a hyperactive Padua factor IX (FIX) protein (BBM-H901) has been developed and is promising for haemophilia B gene therapy. We aimed to explore its safety and activity in increasing FIX concentrations and reducing bleeding frequency.We did a single-centre, single-arm, phase 1, pilot trial evaluating the safety and activity of a single intravenous infusion of BBM-H901 at the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (Tianjin, China). We enrolled adult patients with haemophilia B (aged >18 years) with baseline FIX coagulation activity (FIX:C) of less than 2 IU/dL, no FIX inhibitor, and low titre of neutralising antibodies (≤1:4) against vector capsid. Eligible participants were intravenously infused with a single dose of 5 × 1012 vector genomes (vg)/kg of BBM-H901 after 1 week of prophylactic prednisone treatment (1 mg/kg per day). Primary endpoints were the incidence of treatment-related adverse events, change in alanine aminotransferase (ALT) and aspartate amino transferase (AST), and development of antibodies against vector capsid within 1 year of infusion. We report the results of the prespecified 1-year analysis following complete enrolment. The trial is registered with ClinicalTrials.gov, NCT04135300, and is complete.Between Oct 16, 2019, and Jan 13, 2021, 12 male participants were assessed, and ten Chinese participants were enrolled and infused with BBM-H901. After a median follow-up of 58 weeks (IQR 51·5-99·5), mean FIX:C reached mean 36·9 IU/dL (SD 20·5). No serious adverse events, no grade 3-4 adverse events were observed. Grade 1-2 adverse events related to BBM-H901 include pyrexia (1 [10%]) and elevation of aminotransferase(1 [10%]). No FIX inhibitors were observed. All participants developed antibodies against vector capsid after infusion. Eight (80%) participants had ALT and AST concentrations below the upper limit of normal throughout the follow-up period. Two (20%) participants had elevation of ALT and AST accompanied with decrease of FIX:C, which remained at 7 IU/dL and 11.8 IU/dL, respectively.This pilot study suggests that liver-tropic BBM-H901 is safe 1 year after infusion. Vector derived FIX:C concentration is sufficiently high to prevent bleeding events and minimise the need for replacement therapy in small populations with haemophilia B. These findings support further study.Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences, National Key Research and Development Program of China, National Natural Science Foundation of China, Tianjin Municipal Science and Technology Commission Grant, and Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
俞若枫完成签到,获得积分0
1秒前
斯文败类应助野子采纳,获得10
1秒前
BlankSpace发布了新的文献求助10
1秒前
大胆的以冬完成签到,获得积分10
1秒前
熬夜才有的双眼皮完成签到,获得积分10
2秒前
3秒前
希望天下0贩的0应助lucky采纳,获得10
3秒前
4秒前
乐观思萱发布了新的文献求助10
5秒前
顺势而为发布了新的文献求助10
6秒前
6秒前
7秒前
9秒前
顺心尔阳完成签到,获得积分10
9秒前
青夏发布了新的文献求助50
9秒前
欣喜的以丹完成签到,获得积分10
10秒前
10秒前
11秒前
leo198611发布了新的文献求助10
11秒前
yeeee发布了新的文献求助10
13秒前
wengly发布了新的文献求助10
13秒前
14秒前
小马甲应助顺势而为采纳,获得10
15秒前
酷波er应助李慧颖采纳,获得10
15秒前
田様应助乐观思萱采纳,获得10
17秒前
曾梦发布了新的文献求助10
18秒前
21秒前
21秒前
隐形曼青应助zzzzzz采纳,获得10
21秒前
wengly完成签到,获得积分10
22秒前
HC3完成签到 ,获得积分10
22秒前
22秒前
逢强必赢完成签到,获得积分10
23秒前
25秒前
曾梦完成签到,获得积分10
25秒前
所所应助阿巴阿巴小聂采纳,获得10
26秒前
打打应助666采纳,获得10
26秒前
MM发布了新的文献求助10
27秒前
李慧颖发布了新的文献求助10
27秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3971606
求助须知:如何正确求助?哪些是违规求助? 3516269
关于积分的说明 11181779
捐赠科研通 3251428
什么是DOI,文献DOI怎么找? 1795887
邀请新用户注册赠送积分活动 876110
科研通“疑难数据库(出版商)”最低求助积分说明 805246